NeuroPace CFO granted RSUs and stock options
NeuroPace Inc Chief Financial Officer Patrick F. Williams reported equity compensation awards consisting of restricted stock units and stock options.
Rhea-AI Filing Summary
NeuroPace Inc Chief Financial Officer Patrick F. Williams reported equity compensation awards consisting of restricted stock units and stock options. He received 16,820 shares of Common Stock as a grant, taking his directly held Common Stock to 68,670 shares after the award.
The grant is in the form of RSUs, each representing one share of common stock upon settlement, with 25% vesting on May 15, 2027 and the remainder vesting in 12 equal quarterly installments thereafter. He was also granted stock options for 44,800 shares at an exercise price of $15.36 per share, expiring on May 14, 2036, with 25% vesting on May 15, 2027 and the rest vesting in 36 equal monthly installments.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 61,620 shares
Grant/Award
2 txns
Insider
Williams Patrick F.
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 44,800 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 16,820 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 44,800 contracts (Direct);
Common Stock — 68,670 shares (Direct)
Footnotes (2)
- F1. Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on May 15, 2027 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter.
- F2. 25% of the shares subject to the option vest on May 15, 2027. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter.
Key Figures
RSU grant: 16,820 shares
Shares owned after grant: 68,670 shares
Stock options granted: 44,800 options
+5 more
8 metrics
RSU grant
16,820 shares
Common Stock represented by RSUs granted to CFO
Shares owned after grant
68,670 shares
Common Stock directly held by CFO following RSU award
Stock options granted
44,800 options
Options on Common Stock granted to CFO
Option exercise price
$15.36 per share
Conversion or exercise price for granted stock options
Option expiration
May 14, 2036
Expiration date of stock option grant
Initial RSU vesting date
May 15, 2027
25% of RSUs vest on this date
RSU remaining vesting pattern
12 quarterly installments
Remaining RSUs vest in 12 equal quarterly installments
Option remaining vesting pattern
36 monthly installments
Remaining option shares vest in 36 equal monthly installments
Key Terms
restricted stock unit, RSU, Stock Option (Right to Buy), vest, +1 more
5 terms
restricted stock unit financial
"Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
RSU financial
"Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right"
Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with an exercise price of $15.3600 per share was granted"
vest financial
"25% of the RSUs vest on May 15, 2027 and the remaining RSUs vest in twelve equal quarterly installments"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"conversion_or_exercise_price of 15.3600 indicates the exercise price of the stock option grant"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What did NeuroPace (NPCE) CFO Patrick Williams report in this Form 4?
NeuroPace CFO Patrick Williams reported equity compensation awards, not market trades. He received 16,820 RSU-based common shares and stock options for 44,800 shares, reflecting routine compensation rather than open-market buying or selling activity.
What are the vesting terms of the NeuroPace (NPCE) RSU grant?
The RSU grant vests over several years. Twenty-five percent of the RSUs vest on May 15, 2027, with the remaining units vesting in twelve equal quarterly installments afterward, creating a long-term, time-based incentive for the CFO’s continued service.
What stock options were granted to the NeuroPace (NPCE) CFO?
Patrick Williams received stock options covering 44,800 shares of NeuroPace common stock. These options have a $15.36 exercise price and expire on May 14, 2036, giving him a long-dated opportunity to purchase shares if performance and conditions warrant.
How do the NeuroPace (NPCE) stock options vest for the CFO?
The stock options vest gradually over time. Twenty-five percent of the option shares vest on May 15, 2027, and the remaining shares vest in thirty-six equal consecutive monthly installments, aligning long-term incentives with the company’s future performance.
Are the NeuroPace (NPCE) CFO transactions open-market buys or sells?
The reported transactions are not open-market buys or sells. They are equity compensation grants of RSUs and stock options at no cash price per share, classified as acquisitions under code “A” for grant or award in the Form 4 instructions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
